IFNA1 and synovial sarcoma: In support of this intervention, recent work demonstrated that JAK inhibitors can ameliorated SS-like manifestations in NOD mice through downregulating IFN pathways.41 Future studies are needed to clarify the pathological connection between IFN signalling and LAMP3 misexpression in patients with SS.